1. Home
  2. TOVX vs LAAC Comparison

TOVX vs LAAC Comparison

Compare TOVX & LAAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • LAAC
  • Stock Information
  • Founded
  • TOVX 2001
  • LAAC 2007
  • Country
  • TOVX United States
  • LAAC Canada
  • Employees
  • TOVX 22
  • LAAC N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • LAAC
  • Sector
  • TOVX Health Care
  • LAAC
  • Exchange
  • TOVX Nasdaq
  • LAAC Nasdaq
  • Market Cap
  • TOVX 3.2M
  • LAAC 542.4M
  • IPO Year
  • TOVX 2006
  • LAAC N/A
  • Fundamental
  • Price
  • TOVX $1.14
  • LAAC $2.74
  • Analyst Decision
  • TOVX Strong Buy
  • LAAC Hold
  • Analyst Count
  • TOVX 1
  • LAAC 3
  • Target Price
  • TOVX $6.00
  • LAAC $5.58
  • AVG Volume (30 Days)
  • TOVX 97.3K
  • LAAC 1.3M
  • Earning Date
  • TOVX 11-12-2024
  • LAAC 11-05-2024
  • Dividend Yield
  • TOVX N/A
  • LAAC N/A
  • EPS Growth
  • TOVX N/A
  • LAAC 3133.17
  • EPS
  • TOVX N/A
  • LAAC 7.78
  • Revenue
  • TOVX N/A
  • LAAC N/A
  • Revenue This Year
  • TOVX N/A
  • LAAC N/A
  • Revenue Next Year
  • TOVX N/A
  • LAAC $208.49
  • P/E Ratio
  • TOVX N/A
  • LAAC $0.35
  • Revenue Growth
  • TOVX N/A
  • LAAC N/A
  • 52 Week Low
  • TOVX $1.14
  • LAAC $2.07
  • 52 Week High
  • TOVX $17.00
  • LAAC $6.69
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 36.15
  • LAAC 36.55
  • Support Level
  • TOVX $1.23
  • LAAC $2.69
  • Resistance Level
  • TOVX $1.21
  • LAAC $3.21
  • Average True Range (ATR)
  • TOVX 0.07
  • LAAC 0.17
  • MACD
  • TOVX 0.01
  • LAAC -0.04
  • Stochastic Oscillator
  • TOVX 0.00
  • LAAC 12.86

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About LAAC Lithium Americas (Argentina) Corp.

Lithium Argentina is a pure-play lithium producer. The company owns two neighboring lithium brine resources in northwest Argentina: Cauchari-Olaroz and Pastos Grandes. Cauchari-Olaroz entered production in 2023, while Pastos Grandes is still in development. Lithium Argentina plans for both resources to be fully integrated with onside downstream processing capabilities and will sell into the lithium chemical market.

Share on Social Networks: